Blue Rock Advisors, LLC Chemo Centryx, Inc. Transaction History

Blue Rock Advisors, LLC

  • $7,000
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$47.25 - $65.16 $2.54 Million - $3.5 Million
-53,784 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$46.35 - $61.69 $2.49 Million - $3.32 Million
53,784 New
53,784 $2.95 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Blue Rock Advisors, LLC Portfolio

Follow Blue Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Rock Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email